Iroko.com
About Iroko.com
Iroko Pharmaceuticals is an innovative, global company founded to acquire, develop and maximize the potential of currently marketed pharmaceutical products. We are led by a senior management team of former executives of major pharmaceutical companies who offer extensive expertise in all key aspects of the industry. In early 2008, Iroko acquired the non-US commercial rights to Aggrastat� (tirofiban HCl) from Merck & Co., Inc.
